drugset / Trial / NCT01411254

Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)

NCT01411254 ↗

Phase 2/3 Completed Santen Pharmaceutical Co., Ltd.

Summary

This study will evaluate the efficacy and safety of Betamethasone Microsphere (DE-102) for diabetic macular edema.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Microsphere Unknown — —